Abbott Laboratories

Abbott Laboratories

Abbott Laboratories is an American global pharmaceuticals and health care products company.

Abbott Laboratories, was founded in 1888 by Dr Wallace C. Abbott and incorporated on March 6, 1900. Four areas in which Abbott operates are pharmaceutical products, diagnostic products, nutritional products and vascular products. Through St. Jude Medical, Inc., Abbott offers products such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products. Abbvie spun off from Abbott Laboratories in 2013 as a research-based biopharmaceutical company.

Abbot products include blood glucose and flash glucose monitoring systems, test strips, sensors, data management decision software, and accessories for people with diabetes, under the FreeStyle brand, and medical devices for the eye, including cataract surgery, laser-assisted in situ keratomileusis (LASIK) surgery, contact lens care products and dry eye products.

Established pharmaceutical products supplied by Abbott include branded generic pharmaceuticals manufactured around the world which are marketed and sold outside the United States. Therapeutic products in this category include gastroenterology products, women's health products, cardiovascular and metabolic products, pain and central nervous system products, and respiratory drugs and vaccines.

Cardiovascular and metabolic products include Lipanthyl and TriCor, for the treatment of dyslipidemia; Teveten and Teveten Plus, for the treatment of essential hypertension; Physiotens, for the treatment of hypertension, and Synthroid, for the treatment of hypothyroidism.

Pain and central nervous system products include Serc, for the treatment of Meniere's disease and vestibular vertigo; Brufen, for the treatment of pain, fever and inflammation, and Sevedol, for the treatment of severe migraines. Respiratory drugs and vaccines include the anti-infective clarithromycin, sold under the brands Biaxin, Klacid, and Klaricid, and Influvac, which is an influenza vaccine.

Nutritional Products include a range of pediatric and adult nutritional products including various forms of prepared infant formula and follow-on formula, including Similac, Similac Pro-Advance, Similac Advance, Similac Pro-Sensitive, Similac Sensitive, Go&Grow by Similac, Similac NeoSure, Similac Organic, Similac Special Care, Similac Total Comfort, Similac For Supplementation, Isomil Advance, Similac Qinti and Eleva; adult and other pediatric nutritional products, including Ensure, Ensure Plus, Ensure Enlive, Ensure Complete, Ensure High Protein, Glucerna, Glucerna Hunger Smart, ProSure, PediaSure, PediaSure Sidekicks, PediaSure Peptide, EleCare, Juven, Abound and Pedialyte; nutritional products, which are used in enteral feeding in healthcare institutions, including Jevity, Osmolite, Oxepa, Freego (Enteral Pump) and Freego sets, Nepro, and Vital, and Zone Perfect bars and the EAS family of nutritional brands, including Myoplex and AdvantEdge.

Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease that are manufactured, marketed and sold around the world. In the United States, these products are marketed and sold to hospitals. Vascular Products include the XIENCE family of drug-eluting coronary stent systems developed on the Multi-Link Vision platform; StarClose SE and ProGlide vessel closure devices; TREK coronary balloon dilatation products; Hi-Torque Balance Middleweight Universal and ASAHI coronary guidewires; MitraClip, a percutaneous mitral valve repair system; Supera Peripheral Stent System, a peripheral vascular stent system, and Acculink/Accunet, and Xact/Emboshield NAV and carotid stent systems.


Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Debt Financing
March 15, 2011
Debt Financing
March 16, 2009
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine



Further reading


A history of Abbott and AbbVie - Pharmaphorum

Hannah Blake


Documentaries, videos and podcasts





Robin Lloyd
August 28, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Carl O'Donnell
May 15, 2020
The U.S. Food and Drug Administration said on Thursday that Abbott Laboratories' speedy coronavirus test, which can deliver results within minutes and is used at the White House, could potentially be inaccurate but can still be used to test patients.
Alex Keown
May 14, 2020
Researchers at a New York hospital compared Abbott's 15-minute Abbott ID NOW test to another COVID-19 diagnostics device and found that the Abbott system missed 48% of positive cases the other device detected.
Christopher Carbone
May 13, 2020
Fox News
The Abbott Laboratories coronavirus test that's been used at the White House to rapidly confirm whether someone is infected may miss as many as half of positive cases, according to a report from New York University.
Alex Keown
May 11, 2020
Approval of Abbott's latest antibody test comes days after the FDA tightened its rules regarding the regulatory requirement for them.
Reuters Editorial
May 8, 2020
Abbott Laboratories' antibody test for the new coronavirus is highly likely to correctly determine whether people have ever been infected with the fast-spreading virus, the company said, citing a U.S. study.
Reuters Editorial
April 15, 2020
Abbott Laboratories Inc said on Wednesday it launched a coronavirus blood test that could show whether a person has been infected and plans to ramp up manufacturing to produce 20 million tests per month by June.
The Associated Press
March 30, 2020
The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments on Monday related to the global economy, the work place and the spread of the virus.
BS Web Team
March 30, 2020
Read more about Market Wrap, March 30: Here's all that happened in the markets today on Business Standard. HDFC, HDFC Bank, ICICI Bank, and Reliance Industries (RIL) contributed the most to the Sensex's losses
Saumya Joseph
October 16, 2019
Abbott Laboratories fell just short of Wall Street estimates for quarterly revenue on Wednesday, as weakness in the medical device maker's cardiovascular business overshadowed strong performance in its fast-growing diabetes care unit.
Reuters Editorial
October 16, 2019
Abbott Laboratories Inc reported a 70.5% jump in quarterly profit on Wednesday, powered by demand for its blood sugar monitors and cardiovascular devices. The company's net earnings rose to $960 million, or 53 cents per share, in the third quarter ended Sept. 30, from $563 million, or 32 cents per share, a year earlier. [nPn4q7c7ya]
August 27, 2019
This study outcome should be a crucial step forward for Abbott Laboratories (ABT) in its endeavor to boost TBI diagnosis and treatment.
Persistence Market Research Pvt. Ltd.
Invalid Date
NEW YORK, December 10, 2018 /PRNewswire/ -- Cardiac marker analyzers to witness promising revenue growth. CLIA analyzers to account for maximum revenue share...


Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.